Literature DB >> 1283002

High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II.

S Lin-Chao1, W T Chen, T T Wong.   

Abstract

The plasmids pUC18 and pUC19 are pBR322 derivatives that replicate at a copy number several fold higher than the parent during growth of Escherichia coli at 37 degrees C. We show here that the high copy number of pUC plasmids results from a single point mutation in the replication primer, RNA II, and that the phenotypic effects of this mutation can be suppressed by the Rom (RNA one modulator)/Rop protein or by lowering the growth temperature to 30 degrees C. The mutation's effects are enhanced by cell growth at 42 degrees C, at which copy number is further increased. During normal cell growth, the pUC mutation does not affect the length or function of RNA I, the antisense repressor of plasmid DNA replication, but may, as computer analysis suggests, alter the secondary structure of pUC RNA II. We suggest that the pUC mutation impedes interactions between the repressor and the primer by producing a temperature-dependent alteration of the RNA II conformation. The Rom/Rop protein may either promote normal folding of the mutated RNA II or, alternatively, may enable the interaction of sub-optimally folded RNA II with the repressor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283002     DOI: 10.1111/j.1365-2958.1992.tb02206.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  56 in total

1.  Multicopy plasmids are clustered and localized in Escherichia coli.

Authors:  J Pogliano; T Q Ho; Z Zhong; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Authors:  Ernesto G Rodríguez
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

3.  A dnaC mutation in Escherichia coli that affects copy number of ColE1-like plasmids and the PriA-PriB (but not Rep-PriC) pathway of chromosomal replication restart.

Authors:  R Harinarayanan; J Gowrishankar
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

4.  Unique plasmids generated via pUC replicon mutagenesis in an error-prone thermophile derived from Geobacillus kaustophilus HTA426.

Authors:  Jyumpei Kobayashi; Misaki Tanabiki; Shohei Doi; Akihiko Kondo; Takashi Ohshiro; Hirokazu Suzuki
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

5.  Comparison of Class 2 Integron Integrase Activities.

Authors:  Xiaotong Wang; Nana Kong; Mei Cao; Long Zhang; Muzhen Sun; Linlin Xiao; Gang Li; Quhao Wei
Journal:  Curr Microbiol       Date:  2021-02-04       Impact factor: 2.188

6.  Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity.

Authors:  Casim A Sarkar; Igor Dodevski; Manca Kenig; Stefan Dudli; Anja Mohr; Emmanuel Hermans; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Timing and dynamics of single cell gene expression in the arabinose utilization system.

Authors:  Judith A Megerle; Georg Fritz; Ulrich Gerland; Kirsten Jung; Joachim O Rädler
Journal:  Biophys J       Date:  2008-05-09       Impact factor: 4.033

8.  The Escherichia coli pcnB gene promotes adenylylation of antisense RNAI of ColE1-type plasmids in vivo and degradation of RNAI decay intermediates.

Authors:  F Xu; S Lin-Chao; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  RNAII transcribed by IPTG-induced T7 RNA polymerase is non-functional as a replication primer for ColE1-type plasmids in Escherichia coli.

Authors:  M Y Chao; M C Kan; S Lin-Chao
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

Review 10.  Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

Authors:  James A Williams; Aaron E Carnes; Clague P Hodgson
Journal:  Biotechnol Adv       Date:  2009-02-20       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.